This article is more than 5 years old. Information may no longer be current.
NYU Langone Medical Center researcher receives award from NCI
Click Here to Manage Email Alerts
Dafna Bar-Sagi , PhD, vice dean for science and chief scientific officer at NYU Langone Medical Center and senior member of its Perlmutter Cancer Center, received an Outstanding Investigator Award from the NCI.
Bar-Sagi will receive $1 million per year for 7 years to fund her research.
NCI Outstanding Investigator Awards are intended to encourage researchers to continue or start research projects of unusual potential. The scientists are able to take greater risks because the awards provide funding for an extended period.
“We are extremely proud Dr. Bar-Sagi's work has been acknowledged in this way,” Robert I. Grossman, MD, dean and CEO of NYU Langone, said in a press release. “Her leadership in cancer research is defined by two principal factors: wide recognition of the importance of her contributions to science, and the influence it bears on the investigative work of others.”
Bar-Sagi’s work has provided insights into the involvement of Ras oncogenes in the regulation of cell proliferation and survival, cellular metabolism, tumor immunity and cell-to-cell signaling. Much of her research has focused on determining how the activation of these processes by Ras oncogenes contribute to the initiation and progression of pancreatic cancer.
“It is a tremendous honor to be recognized in this manner,” Bar-Sagi said in the press release. “This award also acknowledges the numerous contributions of generations of investigators and researchers-in-training whom I have had the pleasure to work with. I am immensely grateful to the NCI for its continued support of our efforts to find a cure for cancer.”